Get startedLog in
    Picture of Enliven Therapeutics logo

    ELVN — Enliven Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    All News

    Brief: Enliven Therapeutics - Increases Authorized Common Stock To 200 Million Shares Effective June 9, 2026 - SEC Filing

    Picture of Enliven Therapeutics logoEnliven Therapeutics
    10/06/2026 11:03
    BRIEF-Enliven Therapeutics - Increases Authorized Common Stock To 200 Million Shares Effective June 9, 2026 - SEC Filing
    June 10 (Reuters) - Enliven Therapeutics Inc ELVN.O:
    • ENLIVEN THERAPEUTICS - INCREASES AUTHORIZED COMMON STOCK TO 200 MILLION SHARES EFFECTIVE JUNE 9, 2026 - SEC FILING
    Source text: []
    Further company coverage: ELVN.O

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Enliven Therapeutics

    See all news